The first compact and easy to use microreactor device for Body On Chip experimen...
The first compact and easy to use microreactor device for Body On Chip experiments.
BEOnChip S.L. is a leading Spanish company focused on the field of Micro-biotechnology.
We have fully engineered microchips that recapitulate the microarchitecture and functions of living human organs. These microchips, called or...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Información proyecto B-On-Chip
Duración del proyecto: 4 meses
Fecha Inicio: 2017-01-23
Fecha Fin: 2017-05-31
Líder del proyecto
BEONCHIP
La fabricación y comercialización de componentes microfluídicos
TRL
4-5
| 505K€
Presupuesto del proyecto
71K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
BEOnChip S.L. is a leading Spanish company focused on the field of Micro-biotechnology.
We have fully engineered microchips that recapitulate the microarchitecture and functions of living human organs. These microchips, called organs-on-chips, can be defined as micro-sized artificial organs and can revolutionize drug development. Now, in the B-On-Chip project we seek bringing to the market the first compact, fully automated and easy-to-use device to link multiple organs-on-chip, enabling the so called body-on-chip experiments. The use of B-On-Chip by the Pharma industry in new drug discovery, has the potential to slash the use of laboratory animals in drug testing. Furthermore, the more realistic data offered by B-On-Chip will accelerate drug development and allow researchers to carry out experiments too risky for human volunteers. Moreover, by linking different organ-on-chips together, it will be possible to study how reactions in one organ affect another. B-On-Chip will offer the most accurate data on new drug efficiency, security, toxicity in a fast, automatic and reliable way, with the breakthrough advantage of being able to offer these results in in vitro experiments.